The cytokine–cytokine receptor interaction (e.g., TNFα/TNFR), JAK-STAT, and other stress response kinases have been targeted with precision drugs, as they were most significantly associated with poor COVID-19 outcomes in transcriptomic and proteomic studies [176]. The gene discussed is TNF; the disease is COVID-19.